The fourth China International Import Expo is to have a special area for biomedicine this year in line with the country's greater emphasis on this key industry. Zhou Naiyuan, deputy director-general of the sci-tech international cooperation department of the National Medical Products Administration, said China’s demand for high-quality drugs will continue to grow as the goal of a "healthy China" is being steadily advanced. The administration pledged to carry out strict supervision on drug safety, constantly push forward regulatory reforms for the industry, and create a more scientific, open and fair policy environment for pharmaceutical market access and supervision.